AnalystBook Research · Company Intelligence

Axil Brands, Inc.

AXILNYSE

Built from Axil Brands, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Axil revenue fell and profit compressed, but cash from ops and free cash flow improved sharply.

The read at a glance✓ Audited against SEC data
  • Business mixHearing protection plus hair and skin careNote
  • RevenueRevenue fell 4.5%Watch
  • ProfitNet income fell 57.3%Watch
  • CashFree cash flow rose to $1.7MOK
  • Balance sheetEquity rose 25.5%; debt fellOK
  • Insiders0 buys / 0 sellsNote
  • AccountingAltman-Z and earnings-quality safeOK

Business

Axil sells hearing enhancement and protection products, plus a smaller hair and skin care business.

Where the revenue comes from

Fiscal 2026, as Axil Brands, Inc. reports it. History and quarterly detail are in the app.

  • Hearing enhancement and protection$29.6M
  • Hair and skin care$1.2M
  • Marketing Services$100K

Leadership changes

From Axil Brands, Inc.'s own filings, the day they're filed.

  • Thomas Penna · director · appointmenteff. 2026-01-15
  • Peter Dunne · Directors · departureeff. 2026-01-15
  • Jeff Brown · Chief Financial Officer · appointmenteff. 2024-05-01

Latest filings

  • 10-K · Annual report2026-08-18
  • 8-K · Company announcement2026-08-18
  • 10-Q · Quarterly report2026-04-08
  • 8-K · Company announcement2026-04-08
  • 8-K · Company announcement2026-01-20
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • Main tension🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Axil Brands, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.